Difference between revisions of "Journal Club"
| Line 3: | Line 3: | ||
|style="color:black; background-color:#dcdcdc;" align="center"|Paper_index | |style="color:black; background-color:#dcdcdc;" align="center"|Paper_index | ||
|style="color:black; background-color:#dcdcdc;" align="center"|Paper_title | |style="color:black; background-color:#dcdcdc;" align="center"|Paper_title | ||
| + | |- | ||
| + | |rowspan = "32" |2012/03/05 | ||
| + | | align="center"|2012-66 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-65 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-64 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-63 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | | align="center"|2012-62 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-61 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-60 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-59 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | | align="center"|2012-58 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-57 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-56 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-55 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | | align="center"|2012-54 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-53 | ||
| + | |[1 2] | ||
| + | |- | ||
| + | |align="center"|2012-52 | ||
| + | |[http://www.nature.com/nature/journal/v483/n7391/full/nature11003.html [ER Kim&TH Kim]The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity] | ||
| + | |- | ||
| + | |align="center"|2012-51 | ||
| + | |[http://www.nature.com/nature/journal/v483/n7391/full/nature11005.html [ER Kim&TH Kim]Systematic identification of genomic markers of drug sensitivity in cancer cells] | ||
| + | |- | ||
| + | | align="center"|2012-50 | ||
| + | |[http://www.pnas.org/content/early/2011/10/13/1018854108.abstract [ER Kim&TH Kim]Subtype and pathway specific responses to anticancer compounds in breast cancer] | ||
| + | |- | ||
| + | |align="center"|2012-49 | ||
| + | |[http://www.nature.com/nature/journal/vaop/ncurrent/full/nature10945.html [JE Shim&KS Kim]De novo mutations revealed by whole-exome sequencing are strongly associated with autism] | ||
| + | |- | ||
| + | |align="center"|2012-48 | ||
| + | |[http://www.nature.com/nature/journal/vaop/ncurrent/full/nature11011.html [JE Shim&KS Kim]Patterns and rates of exonic de novo mutations in autism spectrum disorders] | ||
| + | |- | ||
| + | |align="center"|2012-47 | ||
| + | |[http://www.nature.com/nature/journal/vaop/ncurrent/full/nature10989.html [JE Shim&KS Kim]Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations] | ||
| + | |- | ||
| + | | align="center"|2012-46 | ||
| + | |[http://www.g3journal.org/content/1/3/233.full [T Lee&CY Kim]Integrating Rare-Variant Testing, Function Prediction, and Gene Network in Composite Resequencing-Based Genome-Wide Association Studies (CR-GWAS)] | ||
| + | |- | ||
| + | |align="center"|2012-45 | ||
| + | |[http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1002621 [T Lee&CY Kim]Type 2 Diabetes Risk Alleles Demonstrate Extreme Directional Differentiation among Human Populations, Compared to Other Diseases] | ||
| + | |- | ||
| + | |align="center"|2012-44 | ||
| + | |[http://www.nature.com/nature/journal/v480/n7376/full/nature10665.html [AR Cho&JH Ju]Predicting mutation outcome from early stochastic variation in genetic interaction partners] | ||
| + | |- | ||
| + | |align="center"|2012-43 | ||
| + | |[http://www.sciencemag.org/content/335/6064/82 [AR Cho&JH Ju]Fitness Trade-Offs and Environmentally Induced Mutation Buffering in Isogenic C. elegans] | ||
| + | |- | ||
| + | | align="center"|2012-42 | ||
| + | |[http://genome.cshlp.org/content/early/2012/02/24/gr.130435.111 [JE Shim&KS Kim]Identification of microRNA-regulated gene networks by expression analysis of target genes] | ||
| + | |- | ||
| + | |align="center"|2012-41 | ||
| + | |[http://www.nature.com/ng/journal/v44/n6/full/ng.2303.html [JE Shim&KS Kim]Exome sequencing and the genetic basis of complex traits] | ||
| + | |- | ||
| + | |align="center"|2012-40 | ||
| + | |[http://www.cell.com/abstract/S0092-8674(12)00573-9 [JH Soh]Functional Repurposing Revealed by Comparing S. pombe and S. cerevisiae Genetic Interactions] | ||
| + | |- | ||
| + | |align="center"|2012-39 | ||
| + | |[http://genome.cshlp.org/content/22/2/375.long [ER Kim&TH Kim]De novo discovery of mutated driver pathways in cancer] | ||
| + | |- | ||
| + | | align="center"|2012-38 | ||
| + | |[http://www.nature.com/msb/journal/v4/n1/full/msb20082.html [YH Go&HJ Han]A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas] | ||
| + | |- | ||
| + | |align="center"|2012-37 | ||
| + | |[http://www.nature.com/msb/journal/v7/n1/full/msb201126.html [SH Hwang&HJ Cho]PREDICT: a method for inferring novel drug indications with application to personalized medicine] | ||
| + | |- | ||
| + | |align="center"|2012-36 | ||
| + | |[http://www.nature.com/nature/journal/v453/n7198/full/nature06973.html [SH Hwang&HJ Cho]Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype] | ||
| + | |- | ||
| + | |align="center"|2012-35 | ||
| + | |[http://www.nature.com/nbt/journal/v30/n4/full/nbt.2182.html [JH Shin&HJ Kim]Finding correlations in big data] | ||
|- | |- | ||
|rowspan = "3" |2012/03/05 | |rowspan = "3" |2012/03/05 | ||
Revision as of 14:11, 23 June 2012